ICU kidney injury: does the pattern predict lasting damage?
NCT ID NCT05247502
First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time
Summary
Researchers are studying adults who spend more than a day in intensive care to understand how acute kidney injury affects kidney health months later. The study tracks the occurrence and duration of kidney injury episodes during the ICU stay and measures kidney function at 3 and 12 months after hospitalization. The goal is to see whether specific features of acute kidney injury are linked to major kidney events, including chronic kidney disease, the need for dialysis, or death.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If researchers link specific patterns of acute kidney injury to worse long-term kidney outcomes, doctors could identify high-risk ICU patients earlier and tailor monitoring or treatment after discharge.
- What could go wrong
- This is an observational study with a small number of participants, so it cannot prove cause and effect. The findings may not apply to all ICU patients, and tracking alone does not improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
10 people
The number who actually took part.
- Started
-
Nov 2022
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The MAKI study will recruit a large population of ICU patients. Patients who are hospitalized for more than 24 hours in ICU will be eligible to participate in the study. The MAKE evaluation after different kind of Acute Kidney Injury (MAKI) study will be conducted in 4 ICUs in Clermont-Ferrand, France. All ICU units include both medical and surgical patient recruitment. The patients will be classified into 3 groups based on the occurrence of AKI and its duration: 1) patients without AKI during their stay, 2) patients who had a transient AKI episode (defined as recovery within 48 hours of onset), and 3) patients who had a persistent AKI episode during their stay.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who are hospitalized for more than 24 hours in ICU will be eligible to participate in the study. Exclusion Criteria: * patients who are younger than 18 years, * those who are pregnant, * those who have chronic extrarenal epuration before their admission to the ICU, * those who are admitted for kidney transplantation, * those under the safeguard of justice, and those who refuse to participate in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute kidney injury are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU clermont-ferrand
Clermont-Ferrand, France
-
Centre Jean-Perrin
Clermont-Ferrand, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Common Anti-Nausea drugs under scrutiny for kidney risk during chemo
- Heart attack delay may signal kidney risk after angioplasty
- Can a kidney ultrasound scan warn of kidney damage after heart bypass surgery?
- Two blood tests may separate real kidney harm from a false alarm
- Can watching kidney oxygen during liver surgery keep kidneys safe?
- Can a Citrate-Based blood thinner make continuous kidney dialysis safer?